ADVERTISEMENT

Jacquelyn W Chou, MPP, MPL

Pharma Insights

De-risking Market Launch: Leveraging HEOR Evidence Planning to Support Informed Payer Decisions

12/05/2022

Jacquelyn W. Chou , MPP, MPL;

Andrew Cournoyer , RPh, MBA;

Alexandria Portelli , MPH;

The authors discuss how a strategic HEOR evidence-generation plan that comprehensively communicates the value of a new drug helps to ensure that patients have access to innovative drugs and health care stakeholders have access to data to...

The authors discuss how a strategic HEOR evidence-generation plan that comprehensively communicates the value of a new drug helps to ensure that patients have access to innovative drugs and health care stakeholders have access to data to...

The authors discuss how a...

12/05/2022

Journal of Clinical Pathways

Navigating Pricing Models for COVID-19 Innovations

Pharma Insights

Navigating Pricing Models for COVID-19 Innovations

08/19/2020

Jacquelyn W. Chou , MPP, MPL;

Pricing models are important for decision-making because they help to translate preliminary clinical benefit information into longer-term health benefit and economic value. However, in the face of an on-going global...

Pricing models are important for decision-making because they help to translate preliminary clinical benefit information into longer-term health benefit and economic value. However, in the face of an on-going global...

...

08/19/2020

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement